Evaluation of Pharmacist Intervention for improving Adherence of Immunosuppressive Regimen in Kidney Transplant Recipients
Not Applicable
- Conditions
- Kidney Transplant.Kidney transplant statusZ94.0
- Registration Number
- IRCT20150706023084N9
- Lead Sponsor
- Islamic Azad University, Pharmaceutical Sciences Branch
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 50
Inclusion Criteria
Conscious satisfaction of the patient to participate in the study
Age between 18 to 60 years
Patients with kidney disease confirmed by doctors, kidney transplant have been done and at least 3 years have passed since their transplant
Consumption of Immunosuppressive drug
Exclusion Criteria
Reluctance to continue participating in the study
Drug abuse
Drug allergy
Infection
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What molecular mechanisms underlie immunosuppressive regimen adherence in kidney transplant recipients?
How does pharmacist intervention compare to standard care in managing calcineurin inhibitor adherence post-kidney transplant?
What biomarkers are associated with improved adherence to immunosuppressive agents in renal transplant patients?
What adverse events are commonly reported with calcineurin inhibitors in kidney transplant recipients and how are they managed?
Are there combination approaches involving pharmacist intervention and other immunosuppressive therapies for kidney transplant adherence?